Dianomi Therapeutics Overview

  • Founded
  • 2017

  • Status
  • Out of Business

  • Employees
  • 7

  • Latest Deal Type
  • Out of Business

Dianomi Therapeutics General Information


Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis. The company's mineral coated microparticle (MCM) technology has the ability to provide sustained release delivery of active biologics, an issue many traditional drug delivery systems struggle with, enabling patients to have improved, sustained-release delivery of active biologics.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 504 South Rosa Road
  • Suite 200
  • Madison, WI 53719
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dianomi Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 21-Aug-2022 000.00 Completed Out of Business
4. Early Stage VC (Series A) 09-Feb-2021 000 000.00 0000 Completed Pre-Clinical Trials
3. Angel (individual) 00000 00.00 Completed Pre-Clinical Trials
2. Early Stage VC 04-Feb-2019 $3M $3.19M Completed Pre-Clinical Trials
1. Angel (individual) 25-Jan-2019 $185K $185K Completed Pre-Clinical Trials
To view Dianomi Therapeutics’s complete valuation and funding history, request access »

Dianomi Therapeutics Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially
Madison, WI
7 As of 2022
00000000 00 000.00


labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris n
Cambridge, MA
000 As of 0000
000000 - 000 00000


la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt moll
0000 000000000
Cambridge, MA
00 As of 0000
00.00 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dianomi Therapeutics Competitors (117)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jounce Therapeutics Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 0000000000 Corporation Emeryville, CA 000 00000 000000000 00000
000000000 00000000 Formerly VC-backed Utrecht, Netherlands 00 00.00 000000&0 00.00
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 0000000000 0 00000
You’re viewing 5 of 117 competitors. Get the full list »

Dianomi Therapeutics Patents

Dianomi Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190358344-A1 Mineral coated microparticles for sustained delivery of steroids Inactive 23-May-2018 00000000000

Dianomi Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial